risedronic acid has been researched along with Parodontosis in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scully, C | 1 |
2 other studies available for risedronic acid and Parodontosis
| Article | Year |
|---|---|
One drug tackles two diseases.
Topics: Aged; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Humans; Middle Aged; | 2005 |
Potential adverse effects.
Topics: Bone Density Conservation Agents; Etidronic Acid; Humans; Jaw Diseases; Osteonecrosis; Periodontal D | 2006 |